Freeline Therapeutics(FRLN) - 2021 Q2 - Quarterly Report
Exhibit 99.1 Mr. Bircher will report to Chief Executive Officer Theresa Heggie as part of the executive leadership team. He will bring to Freeline his deep experience leading manufacturing site teams through successful regulatory inspections conducted by the US Food and Drug Administration ("FDA"), including the Center for Biologics Evaluation and Research ("CBER"), the Center for Drug Evaluation and Research ("CDER"), the European Medicines Agency ("EMA") and other regulatory agencies. "Jay's deep knowledg ...